Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Indian In Vitro Diagnostics Market Expected to Grow with a CAGR of 13% During the Forecast Period, 2019-2025 - ResearchAndMarkets.com

October 11, 2019 GMT

DUBLIN--(BUSINESS WIRE)--Oct 11, 2019--

The “Indian In Vitro Diagnostics (IVD) Market By Product Type (IVD Equipment and IVD Reagents); Technology Type; Application Type; End-users - Forecast up to 2025” report has been added to ResearchAndMarkets.com’s offering.

Overview of the Indian IVD Market

The author’s market research report predicts that the Indian IVD Market will grow at a CAGR of ~13.0% during the forecast period 2019-2025.

The market is immensely driven by the increase in the number of chronic and lifestyle-related disorders, increasing cancer incidences, growing awareness on the importance of early diagnosis and prevention, and improving access to healthcare facilities and diagnostic set-ups.

Diagnostic tests are frequently performed in public or private laboratories equipped with suitable and expensive instrumentation along with skilled and trained personnel for analysis. The diagnostics market is experiencing quick progress due to advancements in oncology, molecular diagnostics, point-of-care, and novel sectors such as companion diagnostics in both developed and developing economies. The market is driven by an increase in the elderly population, intensification of chronic diseases, pandemic situations in case of infectious diseases, and the growing importance of medical diagnostics.

Indian IVD Market Research Competitive Analysis

There has been a paradigm shift arising in the implementation of technology and automation. The need for precise and rapid results has resulted in the implementation of high-end products for in-depth evaluation. The Indian government supports Public-Private Partnerships (PPPs) and other innovative schemes to enhance Indian IVD advancement. Foreign Direct Investment (FDI) and domestic study have been encouraged by the government to support the industry. The number of players in the segment offering quality products and after-sales services has risen.

Key Competitive Facts


The report provides complete details about the sub-segments of the Indian IVD market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the disease management in the upcoming years along with details of the existing pure-play companies and new players entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals and to analyze before investing or expanding the business in this market.

Key Takeaways:

Key Topics Covered:

1 Industry Outlook

1.1 IVD Industry Structure and Overview

1.2 Major Market Factors and Growth Drivers

1.3 Total Addressable Market

1.4 Industry Trends

2 Report Outline

2.1 Report Scope

2.2 Report Summary

2.3 Research Methodology

2.4 Report Assumptions

3 Market Snapshot

3.1 Market Definition - Infoholic Research

3.2 Advantages of IVD

3.3 Importance of IVD

3.4 Segmented Addressable Market

3.5 Trends in the Indian In Vitro Diagnostics Market

3.6 Related Market

4 Market Outlook

4.1 Market Segmentation

4.2 PESTEL Analysis

4.3 Porter 5 (Five) Forces

5 Market Characteristics

5.1 DRO - Market Dynamics

5.1.1 Drivers Economic growth, increasing population, urbanization, and rising healthcare expenditure per capita Sedentary lifestyle, increasing prevalence of smoking and alcohol consumption resulting in incidence of lifestyle-related chronic disorders, cancer, and infectious diseases Growing penetration of IVD testing in tier-II and III cities Growing market of biomarker-based and genetic testing in India

5.1.2 Opportunities Point-of-care testing, near patient testing, and home-based testing products and services (direct-to-patient testing services) Adoption of fully automated systems in India and increasing number of phase-III clinical trials in India

5.1.3 Restraints High costs of testing cancer, genetic disorders, and other disease Tightening regulatory requirements but lack of reimbursement policies

5.1.4 DRO - Impact Analysis

5.1.5 Key Stakeholders

6 IVD Market Segments: Reagents and Equipment

7 Technology Types: Market Size and Analysis

7.1 Overview

7.2 Immunoassay

7.3 Biochemistry

7.4 Hematology

7.5 Microbiology

7.6 Blood Gas & Electrolytes

7.7 Molecular Diagnostics

7.8 Urinalysis

7.9 Coagulation

8 Applications: Market Size and Analysis

8.1 Overview

8.2 Oncology

8.3 Infectious Disease

8.4 Diabetes

8.5 Cardiology

8.6 Nephrology

8.7 Autoimmune Disease

8.8 Others

9 End-users: Market Size and Analysis

9.1 Overview

9.2 Hospitals

9.3 Laboratories

9.4 Home Care

9.5 Academic and Research Institutes

9.6 Others

10 Competitive Landscape

10.1 Overview

11 Vendors Profile

11.1 Abbott Laboratories

11.2 Danaher Corporation

11.3 bioMerieux

11.4 F. Hoffmann La Roche

11.5 Siemens

11.6 Transasia Bio-Medical Ltd

12 Companies to Watch for

12.1 Sysmex Corporation

12.2 Thermo Fisher Scientific

12.3 Bio-Rad Laboratories

12.4 Ortho Clinical Diagnostic


12.6 Shanghai Fosun Pharmaceutical Co. Ltd

12.6.1 Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/zd0otg

View source version on businesswire.com:https://www.businesswire.com/news/home/20191011005192/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 10/11/2019 05:54 AM/DISC: 10/11/2019 05:54 AM